Biognosys now distributes software via Thermo Fisher

Biognosys has signed an agreement with a reseller for its vendor-independent software for analyzing proteomics experiments. It means that Thermo Fisher Scientific, based in Waltham, Massachusetts, USA, which claims to be the world's largest supplier for scientific applications, can now offer its mass spectrometry devices together with the Spectronaut software from Biognosys. According to a statement from the Schlieren-based company, Spectronaut is considered the gold standard for proteomics data analysis using data-independent acquisition (DIA).

The added value of this agreement is the simplified access of Thermo Fisher's customers to a comprehensive and optimized system for researching the proteome, i.e. the entirety of all proteins in a cell or organism. Under the terms of the agreement, Biognosys grants Thermo Fisher the rights to list and sell Spectronaut directly in its own product catalog.

The new version Spectronaut 19 was presented in June at the 73rd Annual Conference on Mass Spectrometry and Related Topics in Anaheim, California. It offers algorithms supported by deep learning and improved scalability for the latest generation of instruments.

"Data analysis continues to be a key success factor for mass spectrometry-based proteomics, with enormous potential for further gains," Biognosys CEO and founder Dr. Oliver Rinner is quoted as saying. In many exciting areas, the field of DIA is still emerging as a state-of-the-art recording method. "And this co-selling agreement with Thermo Fischer is an important step towards better accessibility for its customers."

Biognosys is a spin-off of the Swiss Federal Institute of Technology in Zurich and is located in the Bio-Technopark Schlieren-Zurich. ce/mm